Literature DB >> 13768783

A controlled trial of phenylbutazone, oxyphenbutazone, and a placebo in the treatment of rheumatoid arthritis.

R I MEANOCK, E LEWIS-FANING.   

Abstract

Entities:  

Keywords:  ARTHRITIS, RHEUMATOID/therapy; PHENYLBUTAZONE/therapy

Mesh:

Substances:

Year:  1961        PMID: 13768783      PMCID: PMC1007200          DOI: 10.1136/ard.20.2.161

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  The comparative effects of phenylbutazone and G27202 (metabolite I) in patients with rheumatoid arthritis: an assessment of methods for antirheumatic drug evaluation.

Authors:  P P VAUGHN; D S HOWELL; I M KIEM
Journal:  Arthritis Rheum       Date:  1959-06

2.  The status of G-27202 (metabolite 1 of phenylbutazone) in the treatment of rheumatic disorders.

Authors:  W GRAHAM
Journal:  Can Med Assoc J       Date:  1960-05-14       Impact factor: 8.262

3.  Controlled trial of G27 202 (p-hydroxyphenyl-butazone) in rheumatoid arthritis.

Authors:  N CARDOE
Journal:  Ann Rheum Dis       Date:  1959-09       Impact factor: 19.103

4.  Phenylbutazone and its derivatives with special reference to G.27202.

Authors:  F D HART; D BURLEY
Journal:  Br Med J       Date:  1959-04-25

5.  The metabolic fate of phenylbutazone (butazolidin) in man.

Authors:  J J BURNS; R K ROSE; S GOODWIN; J REICHENTHAL; E C HORNING; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1955-04       Impact factor: 4.030

6.  Untoward effects of phenylbutazone (butazolidin)-a re-evaluation.

Authors:  I L SPERLING
Journal:  Arthritis Rheum       Date:  1959-06
  6 in total
  3 in total

1.  Effect of certain anti-arthritic compounds on the permeability of synovial membrane in the rabbit.

Authors:  G W SHARP
Journal:  Ann Rheum Dis       Date:  1963-01       Impact factor: 19.103

2.  Axon reflex sweating in rheumatoid arthritis.

Authors:  J L KALLIOMAKI; H A SAARIMAA; P TOIVANEN
Journal:  Ann Rheum Dis       Date:  1963-01       Impact factor: 19.103

3.  Gold Therapy in Rheumatoid Arthritis: Final Report of a Multicentre Controlled Trial.

Authors: 
Journal:  Ann Rheum Dis       Date:  1961-12       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.